<DOC>
	<DOCNO>NCT00274118</DOCNO>
	<brief_summary>To compare renal consequence two different approach block renin angiotensin system subject hypertension concurrent Type II diabetes mellitus diabetic nephropathy .</brief_summary>
	<brief_title>DETAIL Study : Diabetes Exposed Telmisartan Enalapril</brief_title>
	<detailed_description>The aim study compare renal consequence two different approach block activity renin angiotensin system - Angiotensin II antagonism telmisartan ACE inhibition enalapril - patient hypertension concurrent type II diabetes mellitus diabetic nephropathy . The study design investigate albumin excretion rate short term , long term , assess outcome respect maintenance renal function ( GFR ) incidence clinical endpoint . Study Hypothesis : Association Hypertension Diabetes Essential hypertension account majority hypertension people diabetes , particularly type II diabetes , constitute 90 % dual diagnosis diabetes hypertension . Both diabetes hypertension confer increase cardiovascular risk , patient condition atherogenic risk factor . Albumin Excretion Therapeutic Marker Microalbuminuria early reliable predictor diabetic nephropathy type I - insulin dependent diabetes mellitus ( IDDM ) type II - non insulin dependent diabetes mellitus ( NIDDM ) patient , nephropathy characterise hypertension inevitable decline renal function . Furthermore , diabetic nephropathy single important cause end stage renal failure ( ESRF ) western world recent year incidence ESRF patient type II diabetes dramatically increase . In addition predict nephropathy , type II diabetes , microalbuminuria also predict mortality , major cause death relate cardiovascular disease . Comparison ( ) : Selection ACE Inhibitor Comparative Agent Findings preclinical study animal diabetes mellitus suggest ACE inhibitor reduce glomerular damage one mechanism independent antihypertensive effect . Glomerular efferent arteriolar tone increase diabetic animal result increase transcapillary hydraulic pressure . These alteration may decrease functional integrity glomerular capillary wall . In rat diabetes , long term administration ACE inhibitor diminishes functional morphologic evidence glomerular injury decrease glomerular transcapillary pressure . Removal tonic constrictor effect angiotensin II efferent arteriole would expect low glomerular intracapillary pressure preserve renal plasma flow . Angiotensin II antagonists appear effective ACE inhibitor delay progression renal injury animal model diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>1 . Male female subject age 35 80 year . 2 . Current ACE inhibitor therapy minimum period 3 month prior study entry . 3 . Confirmed diagnosis type II diabetes : Subjects currently treat diet diet oral hypoglycaemic drug , OR Subjects currently treat insulin , history onset diabetes age 40 body weight excess ideal body weight time diagnosis , treat oral agent minimum period two year 4 . On treatment diastolic blood pressure &lt; 95 mmHg . 5 . Documentation normal renal ultrasound within previous 6 month prior inclusion ( alternate method eg pyelography , renal isotope method also acceptable ) . 6 . Mean three consecutive overnight urinary albumin excretion rate &gt; 20 &lt; 1000 g/min end pretreatment observation period . ( A minimum two three sample must &gt; 20 g/min . ) 7 . Glycosylated haemoglobin ( HbA 1c ) &lt; 10 % . 8 . Serum creatinine &lt; 140 mol/L . 9 . Glomerular filtration rate ( GFR ) &gt; 70 ml/min/1.73 m2 . 10 . Ability provide write informed consent . 1 . Type I diabetes mellitus . 2 . Premenopausal woman ( last menstruation &lt; 1 year prior start screen period ) : Who surgically sterile ( tubal ligation , hysterectomy ) Who practise acceptable mean birth control ( plan continue use method throughout study ) . Acceptable method birth control include oral , implantable injectable contraceptive . Who positive serum pregnancy test baseline . 3 . AfroCaribbean subject . 4 . Mean seat SBP &gt; 180 mmHg . 5 . Hepatic dysfunction define follow laboratory parameter : SGPT ( ALT ) SGOT ( AST ) &gt; 1.5 time upper limit normal . 6 . Known cause renal dysfunction diabetic nephropathy . 7 . Subjects solitary kidney know renal artery stenosis . 8 . NYHA functional class CHF II IV . 9 . Known drug alcohol dependency . 10 . Subjects receive investigational therapy within one month provide write informed consent . 11 . Known hypersensitivity telmisartan ACE inhibitor component formulation . 12 . Subjects history suspect angioedema related ACE inhibitor therapy .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>